Navigation Links
Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/11/2011

SAN DIEGO, March 11, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"I am energized and excited by the performance and advancements that Halozyme delivered in 2010 as we executed on our broad clinical development strategies for our rHuPH20 technology," stated Gregory I. Frost, Ph.D., Halozyme's president and CEO. "Halozyme's research pipeline is positioned to achieve value inflection points this year including the results of three Ultrafast Insulin studies and the start of additional clinical trials for PEGPH20 in pancreatic cancer and for HTI-501 to assess its potential utility in cellulite. Our alliance partners should also demonstrate substantial progress in 2011 for products that utilize our technology as Baxter has stated it expects to file a BLA for HyQ (immunoglobulin subcutaneous) and Roche has stated it plans to announce top line data from the pivotal Phase 3 trial for subcutaneous Herceptin®."

Fourth Quarter 2010 and Recent Business Highlights

  • Halozyme began patient dosing for an Ultrafast Insulin clinical trial in type 1 diabetes patients who receive their insulin treatment with a pump. We believe the faster-in and faster-out profile of our Analog Insulin-PH20 makes it well suited to pump applications because it should allow pat
    '/>"/>

    • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
    2. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
    3. Halozyme Therapeutics Realigns Management
    4. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
    5. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
    6. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
    7. Halozyme Therapeutics Announces Public Offering of Common Stock
    8. Halozyme Provides HYLENEX® Product Reintroduction Update
    9. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
    10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
    11. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... ALISO VIEJO, Calif. , May 22, 2013  Avanir ... company management will present an overview of the company at ... Health Care Conference , Presentation date: Wednesday May 29, ... , Jefferies 2013 Global Healthcare Conference , Presentation ... a.m. E.T. A live ...
    (Date:5/22/2013)... , May 22, 2013  Flagship Ventures, ... focused on healthcare and sustainability, today announced the ... as a Senior Partner. In this role, Mr. ... portfolio companies. In addition to working ... Bancel also serves as President and Chief Executive ...
    (Date:5/22/2013)... , May 22, 2013  Grifols, a global healthcare ... presented results from a study demonstrating that a higher ... [Human]) increased levels of the alpha 1 protein ... levels that are considered within the normal range for ... in which low levels of the alpha 1 ...
    Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
    (Date:5/22/2013)... Yoga of Lady Niguma was created by a female yogi (‘yogini’) ... the oldest yoga found in written form (in a book made ... renowned Indian master and yogi Naropa, and the yoga she created ... master. , Lady Niguma taught the practice to her student ... lineage to the second Dalai Lama, Gendun Gyatso. While researching rare ...
    (Date:5/22/2013)... A new study published online today (Thursday) in the ... who visited fast food or chain restaurants in the U.S. ... likely to use calorie information given in the restaurants to ... eating at fast food or chain restaurants twice a week ... as those eating there once a week or less. , ...
    (Date:5/22/2013)... Hosted by the California Dental Association Foundation and ... than $1.6 million in charitable dental services during the ... , The California Dental Association Foundation and the California ... services and oral health education to Californians who experience ... by CDA and CDAF in the past 12 months. ...
    (Date:5/22/2013)... Zensah® Compression Apparel released a statement ... titled "Breast pain while running affects one-third of ... help." According to the article, a British study surveyed ... suffer from breast pain while running but do not ... , Zensah emphasizes the importance for women to ...
    (Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- People ... likely to attempt suicide, whether or not they also ... a new study. "Clinicians who are seeing patients ... at increased risk of suicide," said study co-author Mark ... Resource and Evaluation Center in Ann Arbor, Mich. ...
    Breaking Medicine News(10 mins):Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3
    ... new study from Harvard School of Public Health (HSPH) and ... between the common sexually transmitted infection, Trichomonas vaginalis ... in men. The study appears online on September 9, ... website and will appear in a later print edition. ...
    ... H1N1 influenza vaccine in pregnant women is launching this ... (NIAID), part of the National Institutes of Health, announced ... severe illness if they become infected with influenza virus ... to receive the seasonal influenza vaccine every year," says ...
    ... , , CAMARILLO, Calif., Sept. ... National Science Foundation (NSF) recently honored Dr. Blake Gillespie, Assistant ... Development (CAREER) award. , , The ... and research in protein-ligand interactions and biomolecular dynamics, is supported ...
    ... extend to staph infections, researchers say , WEDNESDAY, Sept. ... anti-microbial properties, might kill MRSA bacteria. , A new ... the honey, made solely from flowers found on the ... FabI protein, which is needed for fatty acid biosynthesis. ...
    ... to awaken dormant, common virus that crosses over into brain ... discovered part of the reason why Tysabri, a drug used ... a rare but potentially deadly brain disease in some patients. ... virus from its slumber, allowing it to cross into the ...
    ... , WASHINGTON, Sept. 9 Statement of ... Legal Reform, on reports from White House press secretary Robert ... tonight,s speech to Congress: , , (Logo: ... "We are encouraged that President Obama understands the tremendous ...
    Cached Medicine News:Health News:Link found between common sexual infection and risk of aggressive prostate cancer 2Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:MRSA May Succumb to Honey 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2